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Feline dry eye syndrome of presumed neurogenic origin: a case report
Abstract
Case summary A 14-year-old female spayed Abyssinian cat, which about 1 year previously underwent
thoracic limb amputation, radiotherapy and chemotherapy for an incompletely excised vaccine-related
fibrosarcoma, was presented for evaluation of corneal opacity in the left eye (OS). The ocular surface of both
eyes (OU) had a lackluster appearance and there was a stromal corneal ulcer OS. Results of corneal
aesthesiometry, Schirmer tear test-1 (STT-1) and tear film breakup time revealed corneal hypoesthesia, and
quantitative and qualitative tear film deficiency OU. Noxious olfactory stimulation caused increased
lacrimation relative to standard STT-1 values suggesting an intact nasolacrimal reflex. Various
lacrimostimulants were administered in succession; namely, 1% pilocarpine administered topically (15 days)
or orally (19 days), and topically applied 0.03% tacrolimus (47 days). Pilocarpine, especially when given
orally, was associated with notable increases in STT-1 values, but corneal ulceration remained/recurred
regardless of administration route, and oral pilocarpine resulted in gastrointestinal upset. Tacrolimus was not
effective. After 93 days, the cat became weak and lame and a low thyroxine concentration was detected in
serum. The cat was euthanized and a necropsy performed. Both lacrimal glands were histologically normal,
but chronic neutrophilic keratitis and reduced conjunctival goblet cell density were noted OU.
Relevance and novel information The final diagnosis was dry eye syndrome (DES) of presumed neurogenic
origin, associated with corneal hypoesthesia. This report reinforces the importance of conducting tearfilm
testing in cats with ocular surface disease, as clinical signs of DES were different from those described in dogs.
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Introduction
Dry eye syndrome (DES), characterized by decreased 
aqueous tear production, is common in companion ani-
mals.1 Although little is known about feline DES, the 
condition is well described in dogs where reported 
causes include immune-mediated dacryoadenitis, con-
genital glandular aplasia/hypoplasia, and drug-induced 
or neurogenic glandular dysfunction.1 Neurogenic DES 
may result from dysfunction of afferent (trigeminal 
nerve) and/or efferent (parasympathetic/sympathetic) 
innervation of the lacrimal glands but is primarily asso-
ciated with parasympathetic dysfunction in dogs.2 To 
our knowledge, neurogenic DES has been reported only 
in cats with dysautonomia.3 The purpose of this report is 
to describe a case of feline neurogenic DES not associ-
ated with dysautonomia, and to detail clinicopathologic 
findings, diagnostic test results and response to therapy.
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Case description
A 13-year-old female spayed Abyssinian cat (3.5 kg) was 
evaluated for incompletely excised grade II thoracic wall 
fibrosarcoma caudal to the right scapula, presumed to be 
vaccine-associated. Results of complete blood count, 
serum biochemistry and urinalysis were within normal 
limits. Feline immunodeficiency virus and feline leuke-
mia virus test results were negative (SNAP FeLV/FIV 
Combo; IDEXX). Evidence of tumor metastasis was not 
detected on thoracic radiographs or abdominal ultra-
sound. Complete amputation of the right forelimb was 
performed, followed by radiotherapy (54 Gy fraction-
ated over 18 sessions of 3 Gy within 3 weeks) and doxo-
rubicin chemotherapy (four doses of 18–20 mg/m2 given 
IV 3 weeks apart). Other than localized alopecia at the 
radiation site, adverse effects were not noted.
One year later (day 0), the cat was re-presented for 
evaluation of a 1 week history of corneal opacity in the 
left eye (OS). Medications at that time included L-lysine 
(500 mg PO q12h); terbutaline (0.625 mg PO q12h) and 
prednisolone (2.5 mg PO q48h) for asthma; tramadol 
(12.5 mg PO as needed) for arthritis; and ondansetron (2 
mg PO q24h as needed) for inappetence. Menace 
response was intact in both eyes (OU). Dazzle and palpe-
bral reflexes, oculocephalic reflex, and direct and con-
sensual pupillary light reflexes were all normal OU. Both 
eyes were open with subtle crusted discharge at the 
medial canthi. The eyelids and meibomian gland pro-
files and orifices were normal OU. The surface of the 
right eye (OD) had a lackluster appearance with a 4 mm 
diameter region of mild superficial fibrosis in the axial 
cornea, which did not retain fluorescein. There was mild 
nuclear sclerosis OD. The ocular surface OS had a lack-
luster appearance and mild diffuse conjunctival hypere-
mia. There was a 5 mm diameter, vascularized, poorly 
demarcated circular ulcer with approximately 30% stro-
mal loss in the temporal region of the left cornea, with 
mild perilesional edema but no malacia or stromal white 
blood cells. Remaining ophthalmic examination findings 
OS were normal other than mild nuclear sclerosis. 
Intraocular pressures (TonoVet; Jorgensen Laboratories) 
were 15 mmHg OU, and Schirmer tear test-1 results 
(STT-1; Merck Animal Health) were 0 mm/min OU. 
Clinical diagnoses were corneal scar OD, corneal stromal 
ulceration OS and reduced aqueous tear production OU. 
Treatment was started with 0.3% ofloxacin ophthalmic 
solution (1 drop OS q8h [Ocuflox; Akorn]) and hyaluro-
nate (1 drop OU q8h [i-drop-Vet Plus; I-MED Pharma]).
On day 11 the ulcer OS had mostly re-epithelialized, 
although stromal loss persisted. However, there were 
numerous punctate areas of fluorescein retention in the 
interpalpebral cornea OS, and an ill-defined area of stip-
pled fluorescein retention in the dorsal cornea OU (Figure 
1a,b). Results of STT-1 (mm/min) were 7 OD and 0 OS. 
Central corneal touch threshold (CTT [Cochet-Bonnet 
aesthesiometer; Luneau Ophtalmologie]; 0.12 mm nylon 
filament) was 1.0 cm OD (equivalent to 12.8 g/mm2) and 
0 cm OS. Mean values for ophthalmically normal non-
brachycephalic cats are 3.5 cm (equivalent to 2.4 g/mm2).4 
Approximately 10 mins following assessment of STT-1, 
the cat’s nasolacrimal reflex was evaluated using a tech-
nique modified from that described in humans.5 Briefly, a 
standard STT strip was placed in the ventrotemporal con-
junctival fornix OU, followed immediately by placement 
of a cotton ball soaked with 70% alcohol close to but not 
touching the cat’s nostrils. After 30 s, the alcohol-soaked 
cotton-ball was removed, but the STT strips were left in 
position for another 30 s. Results (mm/min) were 7 OD 
and 5 OS. Tear film breakup time (TFBUT [DET; Akorn])6 
was 4.0 s OU (reference interval [RI] 9.1–17.7 s).6 The clin-
ical diagnosis was qualitative and quantitative tear film 
dysfunction OU, likely neurogenic in origin. Ofloxacin 
frequency was reduced to 1 drop OS q12h, and hyaluro-
nate was replaced with heterologous feline serum (1 drop 
OU q4h) based upon reports in humans with severe dry 
eye disease.7
Re-examination on day 35 revealed resolution of the 
corneal ulcer OS with resultant focal fibrosis (Figure 1c). 
The STT-1 values (mm/min) were 5 OD and 4 OS. Figure 
2 shows the lacrimostimulant and lacrimomimetic thera-
pies used, as well as STT-1 values over the ensuing 81 
days. Despite improved STT-1 values when 1% pilocar-
pine (Falcon Pharmaceuticals) was administered topi-
cally (days 35–50; 1 drop OU q24h) or orally using an 
escalating dose protocol described for dogs with neuro-
genic DES (days 50–69),2 its use was discontinued owing 
to perceived adverse events. Superficial punctate cor-
neal defects were noted with topical pilocarpine, and 
decreased appetite and a single episode of vomiting and 
excessive salivation were noted when the cat received 
three drops of pilocarpine orally, twice daily. The cat tol-
erated one or two drops orally twice daily. From days 69 
to 116, tacrolimus 0.03% ointment (1/4” strip OU q12h; 
Stokes Pharmacy), heterologous feline serum (1 drop 
OU q4h) and cidofovir 0.5% (1 drop OU q12h) were 
used. No adverse effects were noted and the corneal 
ulcers healed; however, on day 116 the tear film appeared 
lackluster OU and STT-1 values had declined to levels 
similar to those prior to pilocarpine administration (5 
mm/min OD, 4 mm/min OS). Beginning on day 93, the 
cat became weak and developed upper respiratory signs. 
Re-evaluation by an oncologist revealed left thoracic 
limb lameness and cervical pain; caudal brachial plexus 
dysfunction possibly due to sarcoma regrowth or a late 
effect from radiation was suspected. Serum thyroxine 
concentration (total T4) was markedly reduced (<0.5 
µg/dl; RI 1.1–3.3 µg/dl).
The cat’s systemic health continued to decline and on 
day 119 the owners elected euthanasia and consented to 
post-mortem examination. Non-ocular post-mortem 
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findings included monophasic myocardial fibrosis (pre-
sumed to be due to previous infarction), generalized thy-
roid gland atrophy (presumed secondary to radiation 
therapy), and necrotic mucous and plant material within 
bronchioles (presumed to be due to ante-mortem aspira-
tion). Corneal confocal microscopy performed immedi-
ately post-mortem using full-thickness scans set at 3 μm 
increments (Confoscan 4; Nidek) revealed attenuated 
and disorganized corneal epithelium and a diminished to 
regionally absent sub-basal nerve plexus but normal cor-
neal stroma and endothelium OU (Figure 3).8 Histologic 
examination revealed that both corneas had mild neutro-
philic inflammation, neovascularization, anterior stromal 
fibrosis, epithelial attenuation with segmental erosion 
and detachment (Figure 4). There also was multifocal 
lymphoplasmacytic blepharoconjunctivitis OU and mild 
lipogranulomatous blepharitis OS. Conjunctival goblet 
cell density (GCD) was 0% on the anterior and 3% on 
the posterior surfaces (Figure 5) of the third eyelid; 
mean reference values for these locations are 48.8% 
and 12.6%, respectively.9 Small numbers of lympho-
cytes and plasma cells were scattered around individ-
ual tubuloalveolar structures in the orbital lacrimal 
and third eyelid glands OU (Figure 6). Presence of 
feline herpesvirus-1 (FHV-1) DNA in both trigeminal 
ganglia, orbital lacrimal glands and conjunctiva was 
assessed using quantitative PCR (Real-time PCR 
Research and Diagnostics Core Facility, University of 
California-Davis) performed on three 20 µm scrolls cut 
from formalin-fixed, paraffin-embedded blocks of each 
tissue.10 A new microtome blade was used for each tis-
sue. Herpetic DNA was not detected in any tissue.
Figure 1 Clinical images of the ocular surface of the (a,d) right and (b,c,e) left eyes of a 14-year-old female spayed Abyssinian 
cat with neurogenic dry eye syndrome in both eyes on (a,b) days 11, (c) 35 and (d,e) 63 after initial presentation
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Discussion
To our knowledge, this is the first report of feline 
neurogenic DES not associated with dysautonomia. 
This diagnosis was based on clinically evident kerato- 
conjunctivitis, markedly reduced corneal sensitivity, 
reduced to absent STT-1 values without other 
detected cause and clinical response to therapies that 
improved STT-1 values. In addition to neurogenic quan-
titative tear film deficiency, it is possible that this cat’s 
qualitative tearfilm deficiency (evidenced by decreased 
GCD and TFBUT) was of neurogenic origin.11 However, 
it could also be secondary to chronic ocular surface 
inflammation.12 Despite such profound tearfilm defi-
ciency, this cat did not have hallmark signs of canine DES 
(ie, ‘keratoconjunctivitis sicca’ or KCS), such as blepha-
rospasm, mucoid discharge, or corneal vascularization, 
keratinization or melanosis. Rather, clinical evidence of 
DES in this cat was more subtle and included chronic, 
non-healing superficial corneal ulceration, superficial 
punctate fluorescein stain retention, a lackluster corneo-
conjunctival surface and mild-to-moderate conjunctival 
hyperemia. To differentiate canine and feline syndromes, 
here we have used  the term DES rather than KCS.
Several factors indicate that neuronal dysfunction 
was the likely cause of DES in this cat. These include: 
(1) markedly decreased corneal sensitivity; (2) increased 
lacrimation in response to a noxious olfactory stimulus; 
(3) response to parasympathomimetic therapy; (4) lack 
of response to immunomodulatory therapy known 
to work in humans and dogs with immune-mediated 
dacryoadenitis; and (5) lack of histologic evidence of 
lacrimal gland pathology sufficient to explain immune-
mediated dysfunction. Furthermore, reduced corneal 
sensitivity, normal lacrimal gland histology, increased 
STT-1 values OS following stimulation of the nasolacri-
mal reflex and increased STT-1 values in response to 
pilocarpine therapy all suggest that the lacrimal glands 
and their parasympathetic innervation retained func-
tion, and that corneal hypoesthesia was largely or 
solely responsible for this cat’s DES. Testing the nasol-
acrimal reflex was particularly illuminating in this cat 
and warrants further study. Physiologic tear volume 
regulation and reflex tearing measured with the STT-1 
require functional corneal innervation via the long cili-
ary nerves,13 whereas the nasolacrimal reflex relies 
upon stimulation of the nasociliary nerves which are 
sensory to the nasal mucosa rather than the cornea, and 
are not involved in normal physiologic tear volume 
regulation.14
The cause of neurogenic dysfunction in this cat is 
unclear. Recurrent corneal ulceration led to initial suspi-
cion of FHV-1 as a causative agent, especially because 
chronic herpetic infection in humans can lead to trigem-
inal nerve dysfunction and resultant corneal hypoesthe-
sia and decreased lacrimation,15 as seen in this cat. 
However, failure to detect FHV-1 DNA in the lacrimal 
glands, trigeminal ganglia or conjunctiva bilaterally 
argues against this. Rather, it seems more likely 
that dysfunction of afferent nerve fibers responsible 
for lacrimation may have resulted from peripheral 
Figure 2 Time course describing lacrimostimulant and lacrimomimetic therapy, as well as Schirmer tear test-1 (STT-1) values 
for the right eye (dark gray) and left eye (light gray) of a 14-year-old female spayed Abyssinian cat with neurogenic dry eye 
syndrome in both eyes. The horizontal dashed line represents the minimum STT-1 value considered normal in cats (9 mm/min).6 
Day number is relative to initial presentation
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Figure 3 Confocal photomicrographs of the cornea of a 14-year-old female spayed Abyssinian cat with neurogenic dry eye 
syndrome in both eyes. Note the (a) thin, disorganized epithelium with few hyper-reflective epithelial cells and leukocytes 
scattered within superficial to intermediate epithelial layers; (b) diminished to regionally absent sub-basal nerve plexus; 
(c) normal oval-shaped and elongated nuclei of keratocytes in the mid corneal stroma; and (d) normal corneal endothelial 
morphology and cell density (2400 cells/mm2; reference value 2520 cells/mm2).8 Bar = 50 µm
Figure 4 Photomicrographs of the cornea (a) OD and (b) OS of a 14-year-old female spayed Abyssinian cat with neurogenic 
dry eye syndrome OU. Both corneas had mild neutrophilic inflammation (black arrowhead), neovascularization (white arrow), 
anterior stromal fibrosis (asterisk), epithelial attenuation with segmental erosion and detachment (black arrow). Bar = 200 µm 
for gross images and 50 µm for insets
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neuropathy of a different cause, perhaps as a result of 
hypothyroidism or radiation injury. Hypothyroidism 
has been linked to DES in dogs,16 horses17 and humans,18 
and peripheral neuropathy is the most common neuro-
logic manifestation of hypothyroidism in companion 
animals.19 However, serum thyroid concentration was 
not assessed in our cat until 104 days after the diagnosis 
of neurogenic DES, and the cat was euthanized soon 
afterwards. Therefore, it is unclear whether hypothy-
roidism existed prior to development of neurogenic 
DES, or whether thyroid hormone supplementation 
would have restored tear production. 
Therapy for patients with neurogenic DES is chal-
lenging but should include a lacrimomimetic and lacri-
mostimulant, and specific therapy for the cause of 
neurogenic dysfunction where possible. We used topi-
cally applied hyaluronate and heterologous feline 
serum as lacrimomimetics in this cat. Frequently 
applied serum may be superior to artificial tears in 
humans with severe dry eye disease,7 and was well 
tolerated in our patient. We also used pilocarpine in 
this cat for its lacrimostimulant properties; however, 
adverse effects were noted (punctate corneal defects 
and gastrointestinal disturbance). While a causal asso-
ciation between these events and pilocarpine adminis-
tration cannot be confirmed, they limited the client’s 
willingness to continue pilocarpine administration 
despite improved STT-1 values. The other lacrimostim-
ulant used – tacrolimus – did not improve STT-1 val-
ues, which is not surprising given that post-mortem 
examination failed to demonstrate immune-mediated 
dacryoadenitis. However, the closely related com-
pound ciclosporin exerts a direct lacrimogenic effect 
even in eyes without dacryoadenitis,20 and improves 
corneo-conjunctival sensitivity in human patients with 
dry eye.21 Unfortunately, these effects were not investi-
gated in the current case as corneal sensitivity was not 
reassessed after initiation of tacrolimus therapy, and 
ciclosporin was not used.
Conclusions
The ante- and post-mortem diagnosis in the cat presented 
here was neurogenic DES associated with corneal hypoes-
thesia, possibly secondary to hypothyroidism. This 
report suggests that tearfilm deficiency should be sus-
pected in cats with subtle ocular surface disease, and a 
panel of diagnostic tests to characterize the tear volume 
and character, as well as the health of the functional lacri-
mal unit,13 should be conducted, including assessment of 
STT-1, TFBUT, CTT, nasolacrimal reflex, and GCD.
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Figure 6 Photomicrographs of the (a) orbital lacrimal gland 
OD and (b) third eyelid gland OS of a 14-year-old female 
spayed Abyssinian cat with neurogenic dry eye syndrome 
OU. Note the (a) small aggregates of lymphocytes (arrow) 
around lacrimal lobules embedded in adipose tissue OD; and 
(b) mild-to-moderate numbers of perivascular lymphocytes 
and plasma cells (arrowhead) in the lamina propria of the third 
eyelid gland OS. Bar = 100 µm for (a) and 200 µm for (b)
Figure 5 Photomicrographs of the third eyelid OS of a 14-year-
old female spayed Abyssinian cat with neurogenic dry eye 
syndrome OU. Sections were stained using the periodic 
acid–Schiff technique and goblet cells are stained magenta. 
Relative to published reference intervals,9 conjunctival goblet cell 
density is markedly decreased on the (a, arrow) anterior and (b, 
arrowhead) posterior surfaces of the third eyelid. Bar = 100 µm
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